1. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line
- Author
-
Noriyuki Tatsumi, Takahisa Yamane, H. Morii, Yoshiki Nishizawa, Masayuki Hino, and Shinichi Tagawa
- Subjects
endocrine system ,Carcinoma, Hepatocellular ,medicine.medical_treatment ,Molecular Sequence Data ,Biophysics ,Stimulation ,Biochemistry ,fluids and secretions ,Parenchyma ,medicine ,Tumor Cells, Cultured ,Humans ,RNA, Messenger ,RNA, Neoplasm ,Molecular Biology ,Gene ,Thrombopoietin ,DNA Primers ,Messenger RNA ,Base Sequence ,Chemistry ,Growth factor ,food and beverages ,hemic and immune systems ,Cell Biology ,Ligand (biochemistry) ,Molecular biology ,Gene Expression Regulation, Neoplastic ,Liver ,embryonic structures ,Cancer research ,Cytokines ,Hepatocyte growth factor ,medicine.drug - Abstract
The gene of thrombopoietin (TPO) has been cloned and identified to be identical to gene of the c-mpl ligand. It is known that the mRNA of TPO is expressed in liver and kidney. However, it is not clarified which cells in the liver produce TPO. Using a human hepatoma cell line, HepG2, we demonstrated that the TPO mRNA was expressed by liver parenchymal cells without any stimulation. To clarify the regulation of the expression of the TPO mRNA in HepG2 cells by cytokines, we assessed the effects of 5 cytokines, transforming growth factor-β1, activin A, platelet-derived growth factor, hepatocyte growth factor, and interleukin-6. These cytokines have no significant regulative effect on the expression of the TPO mRNA in HepG2 cells. Our results suggest that liver parenchymal cells may be the TPO producing cells and also suggest that some hepatoma cells may produce TPO constitutively.
- Published
- 1995